Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial

IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the standard dose, reducing the risk of symptomatic intracerebral hemorrhage. There is uncertainty, however, over how this effect translates into an overall clinical benefit for patients with acute ischemic...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JAMA Neurol
Huvudupphovsmän: Wang, Xia, Robinson, Thompson G., Lee, Tsong-Hai, Li, Qiang, Arima, Hisatomi, Bath, Philip M., Billot, Laurent, Broderick, Joseph, Demchuk, Andrew M., Donnan, Geoffrey, Kim, Jong S., Lavados, Pablo, Lindley, Richard I., Martins, Sheila O., Olavarria, Veronica V., Pandian, Jeyaraj D., Parsons, Mark W., Pontes-Neto, Octavio M., Ricci, Stefano, Sharma, Vijay K., Thang, Nguyen H., Wang, Ji-Guang, Woodward, Mark, Anderson, Craig S., Chalmers, John
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Medical Association 2017
Ämnen:
Original Investigation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822216/
https://ncbi.nlm.nih.gov/pubmed/28973174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2286
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk